Hearing and hair cells are protected by adenoviral gene therapy with TGF-β1 and GDNF

Kohei Kawamoto, Masao Yagi, Timo Stöver, Sho Kanzaki, Yehoash Raphael

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Glial cell line-derived neurotrophic factor (GDNF) overexpression in the inner ear can protect hair cells against degeneration induced by aminoglycoside ototoxicity. The protective efficiency of GDNF increases when it is combined with co-factors such as transforming growth factor β1 (TGF-β1), a ubiquitous cytokine. The aim of this study was to determine whether TGF-β1 receptors are expressed in the inner ear and whether a cocktail of GDNF and TGF-β1 transgenes provides enhanced protection of the inner ear against ototoxic trauma. Using RT-PCR analysis, we determined that both TGF-β1 receptors, type 1 and 2 are present in rat cochlea. We co-inoculated two adenoviral vectors, one encoding human TGF-β1 gene (Ad.TGF-β1) and the other encoding human GDNF gene (Ad.GDNF) into guinea pig cochleae 4 days prior to injecting an ototoxic dose of aminoglycosides. Inoculated ears had better hearing and fewer missing inner hair cells after exposure to the aminoglycoside ototoxicity, as compared with controls and ears treated only with Ad.GDNF. Cochleae with TGF-β1 overexpression exhibited fibrosis in the scala tympani regardless of the presence of GDNF. Our results suggest that the adenovirus-mediated overexpression of GDNF and TGF-β1 can be used in combination to protect cochlear hair cells and hearing from ototoxic trauma.

Original languageEnglish
Pages (from-to)484-492
Number of pages9
JournalMolecular Therapy
Volume7
Issue number4
DOIs
Publication statusPublished - 2003 Apr 1

Fingerprint

Glial Cell Line-Derived Neurotrophic Factor
Transforming Growth Factors
Genetic Therapy
Hearing
Cochlea
Aminoglycosides
Inner Ear
Growth Factor Receptors
Inner Auditory Hair Cells
Ear
Auditory Hair Cells
Scala Tympani
Wounds and Injuries
Transgenes
Adenoviridae
Genes
Guinea Pigs
Fibrosis
Cytokines
Polymerase Chain Reaction

Keywords

  • Cochlea
  • GDNF
  • Gene therapy
  • Guinea pig
  • Ototoxicity
  • Protection
  • TGF-β1

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Hearing and hair cells are protected by adenoviral gene therapy with TGF-β1 and GDNF. / Kawamoto, Kohei; Yagi, Masao; Stöver, Timo; Kanzaki, Sho; Raphael, Yehoash.

In: Molecular Therapy, Vol. 7, No. 4, 01.04.2003, p. 484-492.

Research output: Contribution to journalArticle

Kawamoto, Kohei ; Yagi, Masao ; Stöver, Timo ; Kanzaki, Sho ; Raphael, Yehoash. / Hearing and hair cells are protected by adenoviral gene therapy with TGF-β1 and GDNF. In: Molecular Therapy. 2003 ; Vol. 7, No. 4. pp. 484-492.
@article{afdb82b2c80c4f1c8b3f1cf643e807db,
title = "Hearing and hair cells are protected by adenoviral gene therapy with TGF-β1 and GDNF",
abstract = "Glial cell line-derived neurotrophic factor (GDNF) overexpression in the inner ear can protect hair cells against degeneration induced by aminoglycoside ototoxicity. The protective efficiency of GDNF increases when it is combined with co-factors such as transforming growth factor β1 (TGF-β1), a ubiquitous cytokine. The aim of this study was to determine whether TGF-β1 receptors are expressed in the inner ear and whether a cocktail of GDNF and TGF-β1 transgenes provides enhanced protection of the inner ear against ototoxic trauma. Using RT-PCR analysis, we determined that both TGF-β1 receptors, type 1 and 2 are present in rat cochlea. We co-inoculated two adenoviral vectors, one encoding human TGF-β1 gene (Ad.TGF-β1) and the other encoding human GDNF gene (Ad.GDNF) into guinea pig cochleae 4 days prior to injecting an ototoxic dose of aminoglycosides. Inoculated ears had better hearing and fewer missing inner hair cells after exposure to the aminoglycoside ototoxicity, as compared with controls and ears treated only with Ad.GDNF. Cochleae with TGF-β1 overexpression exhibited fibrosis in the scala tympani regardless of the presence of GDNF. Our results suggest that the adenovirus-mediated overexpression of GDNF and TGF-β1 can be used in combination to protect cochlear hair cells and hearing from ototoxic trauma.",
keywords = "Cochlea, GDNF, Gene therapy, Guinea pig, Ototoxicity, Protection, TGF-β1",
author = "Kohei Kawamoto and Masao Yagi and Timo St{\"o}ver and Sho Kanzaki and Yehoash Raphael",
year = "2003",
month = "4",
day = "1",
doi = "10.1016/S1525-0016(03)00058-3",
language = "English",
volume = "7",
pages = "484--492",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Hearing and hair cells are protected by adenoviral gene therapy with TGF-β1 and GDNF

AU - Kawamoto, Kohei

AU - Yagi, Masao

AU - Stöver, Timo

AU - Kanzaki, Sho

AU - Raphael, Yehoash

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Glial cell line-derived neurotrophic factor (GDNF) overexpression in the inner ear can protect hair cells against degeneration induced by aminoglycoside ototoxicity. The protective efficiency of GDNF increases when it is combined with co-factors such as transforming growth factor β1 (TGF-β1), a ubiquitous cytokine. The aim of this study was to determine whether TGF-β1 receptors are expressed in the inner ear and whether a cocktail of GDNF and TGF-β1 transgenes provides enhanced protection of the inner ear against ototoxic trauma. Using RT-PCR analysis, we determined that both TGF-β1 receptors, type 1 and 2 are present in rat cochlea. We co-inoculated two adenoviral vectors, one encoding human TGF-β1 gene (Ad.TGF-β1) and the other encoding human GDNF gene (Ad.GDNF) into guinea pig cochleae 4 days prior to injecting an ototoxic dose of aminoglycosides. Inoculated ears had better hearing and fewer missing inner hair cells after exposure to the aminoglycoside ototoxicity, as compared with controls and ears treated only with Ad.GDNF. Cochleae with TGF-β1 overexpression exhibited fibrosis in the scala tympani regardless of the presence of GDNF. Our results suggest that the adenovirus-mediated overexpression of GDNF and TGF-β1 can be used in combination to protect cochlear hair cells and hearing from ototoxic trauma.

AB - Glial cell line-derived neurotrophic factor (GDNF) overexpression in the inner ear can protect hair cells against degeneration induced by aminoglycoside ototoxicity. The protective efficiency of GDNF increases when it is combined with co-factors such as transforming growth factor β1 (TGF-β1), a ubiquitous cytokine. The aim of this study was to determine whether TGF-β1 receptors are expressed in the inner ear and whether a cocktail of GDNF and TGF-β1 transgenes provides enhanced protection of the inner ear against ototoxic trauma. Using RT-PCR analysis, we determined that both TGF-β1 receptors, type 1 and 2 are present in rat cochlea. We co-inoculated two adenoviral vectors, one encoding human TGF-β1 gene (Ad.TGF-β1) and the other encoding human GDNF gene (Ad.GDNF) into guinea pig cochleae 4 days prior to injecting an ototoxic dose of aminoglycosides. Inoculated ears had better hearing and fewer missing inner hair cells after exposure to the aminoglycoside ototoxicity, as compared with controls and ears treated only with Ad.GDNF. Cochleae with TGF-β1 overexpression exhibited fibrosis in the scala tympani regardless of the presence of GDNF. Our results suggest that the adenovirus-mediated overexpression of GDNF and TGF-β1 can be used in combination to protect cochlear hair cells and hearing from ototoxic trauma.

KW - Cochlea

KW - GDNF

KW - Gene therapy

KW - Guinea pig

KW - Ototoxicity

KW - Protection

KW - TGF-β1

UR - http://www.scopus.com/inward/record.url?scp=0037689449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037689449&partnerID=8YFLogxK

U2 - 10.1016/S1525-0016(03)00058-3

DO - 10.1016/S1525-0016(03)00058-3

M3 - Article

C2 - 12727111

AN - SCOPUS:0037689449

VL - 7

SP - 484

EP - 492

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 4

ER -